Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Feb;63(2):632–639. doi: 10.1128/iai.63.2.632-639.1995

Extracellular virulence factors in Bacillus cereus endophthalmitis: methods and implication of involvement of hemolysin BL.

D J Beecher 1, J S Pulido 1, N P Barney 1, A C Wong 1
PMCID: PMC173042  PMID: 7822032

Abstract

Bacillus cereus is a common cause of highly fulminant posttraumatic and metastatic endophthalmitis. Exotoxins or enzymes likely contribute to the severity of the infection, but specific virulence factors have not been identified. We developed two methods for the identification of B. cereus ocular virulence factors. In an in vitro assay that allows screening of multiple samples, retinal toxicity was estimated by measuring the release of lactate dehydrogenase from retinal buttons treated with B. cereus toxins. The results from this assay were confirmed with a sterile endophthalmitis model in which the histopathologic effect of intravitreally injected toxins was assessed. We tested pure hemolysin BL (HBL), a tripartite dermonecrotic vascular permeability factor of B. cereus, and crude exotoxin (CET) preparations, consisting of concentrated, cell-free B. cereus culture supernatant. In the in vitro assay, both CET and HBL caused rapid release of lactate dehydrogenase and retinal disintegration. In vivo, the toxins caused endophthalmitis clinically characteristic of B. cereus within 4 h. Histological changes included rapid retinal necrosis and detachment, choroidal edema, detachment and disruption of the retinal pigment epithelium, and rapid infiltration of polymorphonuclear leukocytes. Neutralization of HBL in CET preparations inhibited toxicity in vitro by 54%, and pure HBL was less toxic than CET with equal HBL contents in both methods. The results suggest that B. cereus ocular virulence is multifactorial and that HBL contributes to virulence.

Full Text

The Full Text of this article is available as a PDF (899.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beecher D. J., MacMillan J. D. A novel bicomponent hemolysin from Bacillus cereus. Infect Immun. 1990 Jul;58(7):2220–2227. doi: 10.1128/iai.58.7.2220-2227.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beecher D. J., Macmillan J. D. Characterization of the components of hemolysin BL from Bacillus cereus. Infect Immun. 1991 May;59(5):1778–1784. doi: 10.1128/iai.59.5.1778-1784.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Beecher D. J., Wong A. C. Identification of hemolysin BL-producing Bacillus cereus isolates by a discontinuous hemolytic pattern in blood agar. Appl Environ Microbiol. 1994 May;60(5):1646–1651. doi: 10.1128/aem.60.5.1646-1651.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Beecher D. J., Wong A. C. Improved purification and characterization of hemolysin BL, a hemolytic dermonecrotic vascular permeability factor from Bacillus cereus. Infect Immun. 1994 Mar;62(3):980–986. doi: 10.1128/iai.62.3.980-986.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Beer P. M., Ludwig I. H., Packer A. J. Complete visual recovery after Bacillus cereus endophthalmitis in a child. Am J Ophthalmol. 1990 Aug 15;110(2):212–213. doi: 10.1016/s0002-9394(14)76999-5. [DOI] [PubMed] [Google Scholar]
  6. DAVENPORT R., SMITH C. Panophthalmitis due to an organism of the Bacillus subtilis group. Br J Ophthalmol. 1952 Jul;36(7):389–392. doi: 10.1136/bjo.36.7.389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Davey R. T., Jr, Tauber W. B. Posttraumatic endophthalmitis: the emerging role of Bacillus cereus infection. Rev Infect Dis. 1987 Jan-Feb;9(1):110–123. doi: 10.1093/clinids/9.1.110. [DOI] [PubMed] [Google Scholar]
  8. Decker T., Lohmann-Matthes M. L. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods. 1988 Nov 25;115(1):61–69. doi: 10.1016/0022-1759(88)90310-9. [DOI] [PubMed] [Google Scholar]
  9. Greenwald M. J., Wohl L. G., Sell C. H. Metastatic bacterial endophthalmitis: a contemporary reappraisal. Surv Ophthalmol. 1986 Sep-Oct;31(2):81–101. doi: 10.1016/0039-6257(86)90076-7. [DOI] [PubMed] [Google Scholar]
  10. Ho P. C., O'Day D. M., Head W. S. Fulminating panophthalmitis due to exogenous infection with Bacillus cereus: report of 4 cases. Br J Ophthalmol. 1982 Mar;66(3):205–208. doi: 10.1136/bjo.66.3.205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jett B. D., Jensen H. G., Nordquist R. E., Gilmore M. S. Contribution of the pAD1-encoded cytolysin to the severity of experimental Enterococcus faecalis endophthalmitis. Infect Immun. 1992 Jun;60(6):2445–2452. doi: 10.1128/iai.60.6.2445-2452.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Le Saux N., Harding G. K. Bacillus cereus endophthalmitis. Can J Surg. 1987 Jan;30(1):28–29. [PubMed] [Google Scholar]
  13. O'Day D. M., Smith R. S., Gregg C. R., Turnbull P. C., Head W. S., Ives J. A., Ho P. C. The problem of bacillus species infection with special emphasis on the virulence of Bacillus cereus. Ophthalmology. 1981 Aug;88(8):833–838. doi: 10.1016/s0161-6420(81)34960-4. [DOI] [PubMed] [Google Scholar]
  14. Peyman G. A., Vastine D. W., Raichand M. Experimental aspects and their clinical application. Ophthalmology. 1978 Apr;85(4):374–385. doi: 10.1016/s0161-6420(78)35659-1. [DOI] [PubMed] [Google Scholar]
  15. Pflugfelder S. C., Flynn H. W., Jr Infectious endophthalmitis. Infect Dis Clin North Am. 1992 Dec;6(4):859–873. [PubMed] [Google Scholar]
  16. Rocha G., Baines M. G., Deschênes J. The immunology of the eye and its systemic interactions. Crit Rev Immunol. 1992;12(3-4):81–100. [PubMed] [Google Scholar]
  17. Schemmer G. B., Driebe W. T., Jr Posttraumatic Bacillus cereus endophthalmitis. Arch Ophthalmol. 1987 Mar;105(3):342–344. doi: 10.1001/archopht.1987.01060030062026. [DOI] [PubMed] [Google Scholar]
  18. Shamsuddin D., Tuazon C. U., Levy C., Curtin J. Bacillus cereus panophthalmitis: source of the organism. Rev Infect Dis. 1982 Jan-Feb;4(1):97–103. doi: 10.1093/clinids/4.1.97. [DOI] [PubMed] [Google Scholar]
  19. Stevens S. X., Jensen H. G., Jett B. D., Gilmore M. S. A hemolysin-encoding plasmid contributes to bacterial virulence in experimental Enterococcus faecalis endophthalmitis. Invest Ophthalmol Vis Sci. 1992 Apr;33(5):1650–1656. [PubMed] [Google Scholar]
  20. Turnbull P. C. Bacillus cereus toxins. Pharmacol Ther. 1981;13(3):453–505. doi: 10.1016/0163-7258(81)90026-7. [DOI] [PubMed] [Google Scholar]
  21. Vahey J. B., Flynn H. W., Jr Results in the management of Bacillus endophthalmitis. Ophthalmic Surg. 1991 Nov;22(11):681–686. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES